BLPH · Categories · Form 4

BLPH - SEC Form 4 insider transactions

Bellerophon Therapeutics Inc. (BLPH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BLPH

• 961d
  Puissance Capital Management Lp sold $111,776 worth of shares (1,076,841 units at $0.10), closing all direct ownership in the company (SEC Form 4)

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Amin Naseem

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Fernandes Peter

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Shah Parag Suresh

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Dekker Martin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Bruder Scott P

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Kim Bobae

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Wang Theodore T

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Cloyd Mary Ann

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1090d
  SEC Form 4 filed by Teufel Crispin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1092d
  SEC Form 4 filed by Puissance Life Science Opportunities Fund Vi

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1108d
  SEC Form 4 filed by Kim Bobae

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1111d
  SEC Form 4 filed by Puissance Life Science Opportunities Fund Vi

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4: Amin Naseem was granted 84,000 shares, increasing direct ownership by 52% to 244,287 units

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Laccona Nicholas

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Shah Parag Suresh

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Teufel Crispin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Dekker Martin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Wang Theodore T

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Fernandes Peter

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Bruder Scott P

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1205d
  SEC Form 4 filed by Cloyd Mary Ann

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1268d
  SEC Form 4: Dekker Martin covered exercise/tax liability with 7,834 shares and converted options into 25,500 shares

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1268d
  SEC Form 4: Fernandes Peter converted options into 32,500 shares and covered exercise/tax liability with 9,985 shares

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1268d
  SEC Form 4: Shah Parag Suresh converted options into 25,500 shares and covered exercise/tax liability with 7,834 shares

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1268d
  SEC Form 4: Laccona Nicholas converted options into 18,000 shares and covered exercise/tax liability with 5,530 shares

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1587d
  SEC Form 4 filed by Fernandes Peter

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1587d
  SEC Form 4 filed by Dekker Martin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1587d
  SEC Form 4 filed by Shah Parag Suresh

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1587d
  SEC Form 4 filed by Laccona Nicholas

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1611d
  SEC Form 4 filed by Wang Theodore T

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1611d
  SEC Form 4 filed by Cloyd Mary Ann

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1611d
  SEC Form 4 filed by Teufel Crispin

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1611d
  SEC Form 4: Amin Naseem was granted 39,032 shares, increasing direct ownership by 32% to 160,287 units

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1611d
  SEC Form 4 filed by Bruder Scott P

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1821d
  SEC Form 4: Puissance Life Science Opportunities Fund VI was granted 8,189 units of Common Stock

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1864d
  SEC Form 4: Puissance Life Science Opportunities Fund VI was granted 609,231 units of Common Stock

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1888d
  SEC Form 4: M Jonathan Peacock was granted 15,308 units of Common Stock, increasing direct ownership by 11% to 157,033 units

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)
• 1899d
  SEC Form 4: Llc Ii, Investments Mountain New sold $2,192,000 worth of Common Stock (400,000 units at $5.48)

  4 - Bellerophon Therapeutics, Inc. (0001600132) (Issuer)

Other BLPH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends